BNKL (Bionik Laboratories) Net Margin %: -270.66% (As of Mar. 2023)

What is Bionik Laboratories Net Margin %?

Bionik Laboratories BNKL -99.00% 12 Net Margin % is -270.66% as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

Net margin is calculated as Net Income divided by its Revenue. Bionik Laboratories's Net Income for the three months ended in Mar. 2023 was $-1.36 Mil. Bionik Laboratories's Revenue for the three months ended in Mar. 2023 was $0.50 Mil. Therefore, Bionik Laboratories's net margin for the quarter that ended in Mar. 2023 was -270.66%.

The historical rank and industry rank for Bionik Laboratories's Net Margin % or its related term are showing as below:

BNKL's Net Margin % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.915
* Ranked among companies with meaningful Net Margin % only.

Bionik Laboratories (OTCPK:BNKL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Bionik Laboratories Net Margin % Related Terms

Bionik Laboratories Net Margin % Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Net Margin % Chart

Bionik Laboratories Annual Data

Trend

Dec14

Dec15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Margin %

Get a 7-Day Free Trial

-325.23

-1,161.91

-1,141.66

-816.95

-274.02

Bionik Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Net Margin %	Get a 7-Day Free Trial															-892.67	-569.55	-232.30	-187.13	-270.66

BNKL vs ARPC, GRST, IONM: Net Margin % Comparison

For the Medical Care Facilities subindustry, Bionik Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's Net Margin % falls into.

Save Embed

12GF Score

Bionik Laboratories Corp BNKL

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bionik Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bionik Laboratories's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-4.946	/	1.805
	=	-274.02 %

Bionik Laboratories's Net Margin for the quarter that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-1.356	/	0.501
	=	-270.66 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -270.66% mean?

Bionik Laboratories (BNKL) has a Net Margin % of -270.66% as of Mar. 2023. Net margin is the ratio of total net income to net sales. View historical data on Bionik Laboratories and its competitors.

Is Bionik Laboratories' Net Margin % too high?

Bionik Laboratories' current Net Margin % is -270.66%. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Bionik Laboratories' Net Margin % compare to ARPC and GRST?

Bionik Laboratories' Net Margin % of -270.66% can be compared against companies in the Healthcare Providers & Services industry. The industry median Net Margin % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Healthcare Providers & Services company?

The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Bionik Laboratories and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionik Laboratories's current Net Margin % is -270.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bionik Laboratories stock overvalued right now?

Bionik Laboratories (BNKL) has a current Net Margin % of -270.66%. The current Net Margin % is -270.66%. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Net Margin % is -270.66% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies ARPC GRST IONM BACK USNU TPIA RHE JRSS HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472

Website https://www.bioniklabs.com

Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.

12GF Score

Get the complete analysis for BNKL

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View BNKL Analysis

See Net Margin % data for all stocks →